Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s DiseaseMorteza Abyadeh, Mehdi Mirzaei, Ghasem Hosseini Salekdeh et al.|Aging and Disease|2021Cited by 62
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspectiveMorteza Abyadeh, Mehdi Mirzaei, Devaraj Basavarajappa et al.|Expert Review of Proteomics|2021Cited by 49
Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s DiseaseMorteza Abyadeh, Mehdi Mirzaei, Ghasem Hosseini Salekdeh et al.|Cells|2022Cited by 36
A Proteomic View of Cellular and Molecular Effects of CannabisMorteza Abyadeh, Mehdi Mirzaei, Ghasem Hosseini Salekdeh et al.|Biomolecules|2021Cited by 34
Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical EvaluationNitin Chitranshi, Vivek Gupta, Angela Godinez et al.|Cells|2021Cited by 30